BXP
46
-9
NRG
57
-5
PG
43
2
JPM
64
-5
GWW
44
-4
ILMN
42
5
F
62
-2
SHW
56
-3
WMT
71
3
SJM
38
2
KMX
57
-2
PEG
48
2
SYK
55
7
CINF
40
-4
GE
72
-5
MTB
50
-5
KEY
57
-3
SE
58
11
WMB
60
-3
AIG
51
-3
BXP
46
-9
NRG
57
-5
PG
43
2
JPM
64
-5
GWW
44
-4
ILMN
42
5
F
62
-2
SHW
56
-3
WMT
71
3
SJM
38
2
KMX
57
-2
PEG
48
2
SYK
55
7
CINF
40
-4
GE
72
-5
MTB
50
-5
KEY
57
-3
SE
58
11
WMB
60
-3
AIG
51
-3
Financhill
Back

NovoCure Vs. Simulations Plus Industry Stock Comparison

Sell
19

NVCR
NovoCure

Last Price:
16.77
Seasonality Move:
7.1%
Buy
55

SLP
Simulations Plus

Last Price:
38.85
Seasonality Move:
7.96%
Sell
19
NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $16.78. The Score for NVCR is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
Simulations Plus (SLP) is a Buy

Is Simulations Plus a Buy, Sell or Hold?

  • The current Simulations Plus [SLP] share price is $38.89. The Score for SLP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SLP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $16.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCR is experiencing slight buying pressure.

SLP Stock Price Chart

What is Simulations Plus's stock price today?

  • The Simulations Plus share price today is $38.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLP is experiencing selling pressure, which indicates risk of future bearish movement.

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.9 Sell
Relative Strength Index (14 RSI): 32.2 Sell
Chaikin Money Flow: 295518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.77 - 22.17) Sell
Bollinger Bands (100): (13.33 - 20.23) Sell

SLP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.23 Sell
Relative Strength Index (14 RSI): 25.84 Sell
Chaikin Money Flow: -135549 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.3 - 49.02) Sell
Bollinger Bands (100): (42.23 - 48.59) Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.34 Sell
20-day SMA: 19.26 Sell
50-day SMA: 18.94 Sell
200-day SMA: 15.36 Buy
8-day EMA: 17.46 Sell
20-day EMA: 18.67 Sell
50-day EMA: 18.56 Sell
200-day EMA: 21.43 Sell

SLP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.47 Sell
20-day SMA: 46.57 Sell
50-day SMA: 47.45 Sell
200-day SMA: 42.53 Sell
8-day EMA: 44.18 Sell
20-day EMA: 46.04 Sell
50-day EMA: 46.52 Sell
200-day EMA: 44.33 Sell

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.01 per share, an increase this year of $0.42 per share, and a decrease next year of $0.10 per share.

Simulations Plus Earnings Growth & SLP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.11 per share, and an increase next year of $0.13 per share.

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Simulations Plus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):